ClinicalTrials.Veeva

Menu
R

Retina Research Center | Austin, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ranibizumab
Bevacizumab
Lampalizumab
Sunitinib Malate
Triamcinolone Acetonide
Pegcetacoplan
GB-102
-Ranibizumab
APL-2
Aflibercept

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 59 total trials

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join...

Enrolling
Diabetic Retinopathy
Drug: BI 764524
Drug: Aflibercept (Eylea®) - US only

This is a phase 3, open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan (APL-2) in subjects with g...

Active, not recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: PEGCETACOPLAN (APL-2)

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (axitinib implant) in Subjects with Neovascular Age-Related Macular Degeneration

Enrolling
Neovascular Age-Related Macular Degeneration
Drug: OTX-TKI (axitinib implant)
Drug: Aflibercept

Trial sponsors

Jaeb Center for Health Research logo
Roche logo
Pfizer logo
T
A
Boehringer Ingelheim logo
Genentech logo
G
L
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems